UHN Investigators awarded CIHR Proof-of-Principle grants - UHN TDC is pleased to announce the funding for two CIHR Proof-of-Principle Phase II projects.
This unique CIHR-matched “gap funding” program is targeted...Read more... |
RaySearch Licenses Groundbreaking Technology from Princess Margaret Hospital -
Stockholm, March 7, 2011 - RaySearch Laboratories AB (publ.) has entered into an exclusive license agreement with Princess Margaret Cancer Centre in Toronto, Read more... |
TDC is pleased to offer all current UHN technologies available for licensing to interested partners in a convenient booklet, memory stick or CD (to request a copy please contact tdc@uhnresearch.ca). Alternatively these technologies can be viewed online. |
TDC Inaugural Report - This report highlights UHN's technologies developed through industry partnerships that are already making patient impact.
Read more... |
Fei-Fei Liu
Conducting groundbreaking cancer research at the Princess Margaret Cancer Centre, part of UHN, Dr. Fei-Fei Liu has recently published her work in the prestigious journal Science Translational Medicine.
Read more... |
A New Handheld Optical Molecular Imaging Platform for Wound Care (and Other Applications)
Researchers at UHN have recently developed an innovative and handheld optical molecular imaging device that enables point-of-care analysis of acute and chronic wound infections using biophotonic technologies.
Read more... |
